metrizamide การใช้

• Historically Metrizamide replaced Pantopaque as the contrast agent of choice for Myelography.
• With Metrizamide the issue is that if entering the cranial cavity and high dose exposure to the blood brain barrier, side effects are more likely encountered.
• The radio opacity characteristics are such that finer detail is displayed with Metrizamide as well as the advantage of reabsorption from spinal fluid and excretion from the body.